Funding for this research was provided by:
Ministry of Health, Labour and Welfare (2014-2016)
Text and Data Mining valid from 2019-02-19
Received: 26 December 2018
Accepted: 17 January 2019
First Online: 19 February 2019
Compliance with ethical standards
: The first author AN, and the corresponding author and the representative of the Guideline Development Committee Members NS declare that they have no conflicts of interest (COIs). Some of the other authors received lecture fees, research funds, scholarships or incentive donations from Teijin Pharma ltd, Sanwa Kagaku Kenkyusho Co., Ltd., Fujiyakuhin Co., Ltd, and Torii Pharmaceutical Co., Ltd. For the reported COIs shown above, the Guideline Developing Committee has devised measures to avoid the influence of their COIs regarding guideline development. See Supplementary Material for the detail of COIs and its counter measures.